{"id":43874,"date":"2020-08-03T12:11:13","date_gmt":"2020-08-03T20:11:13","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/08\/03\/fda-approves-gw-pharmaceuticals-cannabis-drug-for-new-indication\/"},"modified":"2020-08-03T13:45:27","modified_gmt":"2020-08-03T21:45:27","slug":"fda-approves-gw-pharmaceuticals-cannabis-drug-for-new-indication","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/08\/03\/fda-approves-gw-pharmaceuticals-cannabis-drug-for-new-indication\/","title":{"rendered":"FDA approves GW Pharmaceuticals\u2019 cannabis drug for new indication"},"content":{"rendered":"<\/p>\n<p>CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain\u2019s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with two forms of severe epilepsy, Lennox-Gastaut [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/fda-approves-gw-pharmaceutical-cannabis-drug-epidiolex-for-new-indication\/\">FDA approves GW Pharmaceuticals\u2019 cannabis drug for new indication<\/a> is a post from: <a href=\"https:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/fda-approves-gw-pharmaceutical-cannabis-drug-epidiolex-for-new-indication\/\" target=\"_blank\" rel=\"noopener noreferrer\">FDA approves GW Pharmaceuticals\u2019 cannabis drug for new indication<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain\u2019s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with two<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/08\/03\/fda-approves-gw-pharmaceuticals-cannabis-drug-for-new-indication\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[713,9662,136,4720,3156,9664,1170,3157,2786,4721,9693,14144,2313,9663],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/43874"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=43874"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/43874\/revisions"}],"predecessor-version":[{"id":43875,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/43874\/revisions\/43875"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=43874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=43874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=43874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}